IR inactivation using inhibitors or caloric restriction to lower blood glucose levels can be used clinically to reduce circulating insulin levels; however, these strategies are practically infeasible for patients with severe diabetes who need exogenous insulin administration. The gene discussed is INS; the disease is diabetes mellitus.